First Trust Health Care AlphaDEX Fund Rating $131.52 +0.02 (+0.01%) As of 02:25 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock First Trust Health Care AlphaDEX Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FXH Aggregate RatingModerate Buy 2.60Holdings in FXH have an aggregate rating of Moderate Buy based on 483 analyst ratings issued in the past year covering 25 companies (53.8% of the portfolio).FXH Aggregate Price Target$131.49-0.02% DownsideHigh Prediction$131.49Average Prediction$131.49Low Prediction$131.49Holdings in FXH have an aggregate price target of $131.49 and a range of $131.49 to $131.49 covering 25 companies (53.8% of the portfolio).FXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Health Care AlphaDEX Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FXH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.66%REGNRegeneron Pharmaceuticals$804.43-0.2%3.78 of 5 stars2.62$793.74 -1.3%26Insider Trade2.53%SOLVSolventum$89.19+3.2%2.7841 of 5 stars2.46$91.64 2.7%132.48%ZBHZimmer Biomet$100.25+0.7%3.2267 of 5 stars2.22$104.42 4.2%232.47%UHSUniversal Health Services$170.39-0.5%4.6502 of 5 stars2.29$204.93 20.3%17Analyst Revision2.42%BSXBoston Scientific$52.15+0.9%4.9429 of 5 stars2.71$71.62 37.3%31Trending NewsGap Up2.41%DVADaVita$181.18+1.1%4.7621 of 5 stars2.38$221.75 22.4%82.35%CICigna Group$281.53+1.3%4.9773 of 5 stars2.68$339.45 20.6%22Positive News2.33%PFEPfizer$26.88+0.3%3.6971 of 5 stars2.19$28.28 5.2%21Trending NewsAnalyst Revision2.28%GMEDGlobus Medical$85.79-0.2%3.7365 of 5 stars2.88$101.77 18.6%172.28%CORTCorcept Therapeutics$114.64+3.7%3.3707 of 5 stars2.63$119.17 3.9%8Positive NewsInsider Trade2.28%GHGuardant Health$157.99-1.0%3.2473 of 5 stars2.96$183.78 16.3%25Insider Trade2.27%THCTenet Healthcare$267.13+0.0%3.1531 of 5 stars2.95$273.00 2.2%21Analyst UpgradeAnalyst Revision2.23%MDLNMedline$35.66+0.2%4.0563 of 5 stars2.83$47.42 33.0%29Analyst ForecastInsider Trade2.23%NTRANatera$310.41-0.1%2.6901 of 5 stars2.82$319.38 2.9%22Analyst Forecast2.16%AXSMAxsome Therapeutics$215.40+0.8%3.2561 of 5 stars2.82$267.60 24.2%22Earnings ReportAnalyst Forecast2.13%CNCCentene$67.37+2.0%3.3407 of 5 stars2.40$69.15 2.6%20Analyst Upgrade1.85%NBIXNeurocrine Biosciences$153.08+1.5%4.9877 of 5 stars2.88$200.86 31.2%24Analyst Downgrade1.84%MDTMedtronic$91.84+1.4%4.7211 of 5 stars2.67$98.83 7.6%27Positive NewsUpcoming EarningsOptions Volume1.84%EHCEncompass Health$123.79+0.2%4.6769 of 5 stars3.00$148.71 20.1%9Analyst UpgradeInsider Trade1.82%INCYIncyte$120.15-0.3%3.5373 of 5 stars2.43$120.65 0.4%23Analyst Forecast1.80%ARWRArrowhead Pharmaceuticals$87.05+1.7%2.0281 of 5 stars2.62$97.33 11.8%131.80%RMDResMed$225.15-0.7%3.6191 of 5 stars2.44$240.17 6.7%16Analyst UpgradeInsider Trade1.79%HALOHalozyme Therapeutics$98.50-2.2%3.8753 of 5 stars2.62$91.20 -7.4%13Insider Trade1.78%ZTSZoetis$74.16-2.2%4.7853 of 5 stars2.32$109.62 47.8%19Analyst Forecast1.78%QGENQiagen$42.96-0.6%3.5568 of 5 stars2.36$43.93 2.2%14Options Volume This page (NYSEARCA:FXH) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredWhy I'm sending this one to my own familyBehind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...Behind the Markets | SponsoredCentral banks bought 710 tonnes - this fund pays monthlyGold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredWhy November 27 Is Quickly Becoming America's Most Important Financial Date in DecadesAn estimated $10 trillion could move through a little known government initiative, according to analyst Joel L...Altimetry | SponsoredLeading AI Insider Issues Urgent Market WarningA leading AI pioneer has spent $17 million on AI research and tools since 2022, building a platform now used b...TradeSmith | SponsoredGold buyout deals have handed shareholders overnight gains up to 79 percentGold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Health Care AlphaDEX Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Health Care AlphaDEX Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
